Hemorrhagic cystitis and vesicoureteral reflux secondary to cytotoxic therapy for childhood malignancies.
D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D005134:Eye Neoplasms / Q000188:drug therapy; D005260:Female; D005729:Ganglioneuroma / Q000188:drug therapy; D006417:Hematuria / Q000139:chemically induced*; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011859:Radiography; D012175:Retinoblastoma / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy; D001743:Urinary Bladder / Q000000981:diagnostic imaging; D014718:Vesico-Ureteral Reflux / Q000139:chemically induced* / Q000000981:diagnostic imaging
D003561:Cytarabine; D003520:Cyclophosphamide